English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Mantle cell lymphoma (MCL) is a B-cell malignancy with a broad range of clinical and biological features. Once all MCL patients were considered to have a poor prognosis. However, it is now fully established that a group of MCL patients may experience an indolent disease without needing treatment for

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines